Welcome : Guest

NeoGenomics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about NeoGenomics, Inc., which is principally involved in operating Cancer-Focused Genetic Testing Laboratories. Illustrated with 55 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-18944
Price: $2750
Company Type: Public
Pages: 57
Date: November 2016
Market Data Tables: 55

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Anatomic Pathology......3
Table 1: Anatomic Pathology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Hematoxylin and Eosin, Immunohistochemistry (IHC), In situ hybridization (ISH), Special Stains, Tissue Processing, and Others......3
Breast Cancer Diagnoses......4
Table 2: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......4
Clinical Testing Labs......5
Table 3: Clinical Testing Lab Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Hospital Labs, Independent Clinical Labs, Physician Office Labs and Others......5
Clinical Trials......6
Table 4: Clinical Trials by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Africa, Asia, Australia, Canada, Europe, Mexico, South America, and United States......6
Table 5: Clinical Trials Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value for Cardiovascular, Central Nervous Systems, Infectious Diseases, Oncology, and Others......7
Flow Cytometry......8
Table 6: Flow Cytometry End Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Academic, and Government, Applied, Industrial and Others, and Biotech, Pharma, and CROs......8
Table 7: Flow Cytometry Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Consumables, and Services, and Instrumentation......9
Table 8: Flow Cytometry Market by Application in the US (2015) - Percentage Share Breakdown by Value for Apoptosis, Cell Cycle, Cell Signaling, Cell Storing, Immunophenotyping, Multi Color, Protein Expression, T Cell Immunology, and Others......10
DNA Genotyping Microarray......11
Table 9: Global DNA & Gene Chip (Microarray) Market (2012-2017) in US$ Million......11
Table 10: Global Top 3 DNA Genotyping Microarray Vendors Market Share (2014) by Revenue for Illumina Inc., Affymetrix Inc., Sequenom Inc., and Others......12
Table 11: DNA Microarrays Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cytogenetics, Expression, Genotyping, and Others......13
Genetic Testing......14
Table 12: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......14
Table 13: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......15
Table 14: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......16
Genomic Technology......17
Table 15: Genomic Technology (Academic, Government, Applied Markets, Biopharma, Diagnostic Labs) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......17
Table 16: Genomic Technology for Applied Markets Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......18
Table 17: Genomic Technology for Biopharma Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......19
Table 18: Genomic Technology for Diagnostic Labs Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......20
Table 19: Genomic Technology for Academic/Government Sector by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Digital Polymerase Chain Reaction (dPCR), and Traditional PCR, Fluorescence in Situ Hybridization (FISH), Microarray, Next-Generation Sequencing (NGS), Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, and Other Reagents......21
Genomic Tools......22
Table 20: Genomics Tools Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for DNA Microarrays, Fluorescent in situ hybridization (FISH), Polymerase Chain Reaction (PCR), Sequencing, and Miscellaneous Reagents......22
Table 21: Genomics 2.0 Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......23
Table 22: Genomics 2.0 for Reproductive Health Carrier Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......24
Table 23: Genomics 2.0 for Consumer Genomics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......25
Table 24: Genomics 2.0 for In Vitro Fertilization (IVF) Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......26
Table 25: Genomics 2.0 for Microbiology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......27
Table 26: Genomics 2.0 for Reproductive Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......28
Table 27: Genomics 2.0 for Reproductive Health Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......29
Table 28: Genomics 2.0 for Transplant, Human leukocyte antigen (HLA) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......30
Table 29: Genomics 2.0 Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Oncology, Reproductive, and Others......31
Haemoglobin A1C Test......32
Table 30: Haemoglobin A1C Test Market by Technology in the US (2015) - Percentage Share Breakdown by Value for High Performance Liquid Chromatography (HPLC), and Immunoassy......32
Table 31: Haemoglobin A1C Test Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for High Performance Liquid Chromatography (HPLC), and Immunoassy......33
Table 32: Haemoglobin A1C Test Using High Performance Liquid Chromatography (HPLC) Technology by Country Worldwide (2015) - Percentage Market Share Breakdown by Value for United States, and Others......34
Table 33: Haemoglobin A1C Test Using Immunoassay Technology by Country Worldwide (2015) - Percentage Market Share Breakdown by Value for United States, and Others......35
Oncology Genomics......36
Table 34: Genomics 2.0 for Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......36
Table 35: Genomics 2.0 Market for Oncology by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......37
Table 36: Genomics 2.0 for Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......38
Table 37: Genomics 2.0 for Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for USA, and Others......39
Table 38: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......40
Table 39: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......41
Table 40: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......42
Table 41: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......43
Pathology......44
Table 42: Pathology Market by Service Benefit in Australia (2015) - Percentage Share Breakdown by Value Sales for Esoteric Services and Routine Services......44
Table 43: Pathology Market by Service in Australia (2015) - Percentage Share Breakdown by Value Sales for Esoteric Services and Routine Services......45
Clinical Testing......46
Table 44: Market Shares of Leading Clinical Testing Service Providers Worldwide (2015) - Percentage Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics, Inc., and Others......46
Table 45: Market Shares of Leading Clinical Testing Service Providers in Japan (2015) - Percentage Breakdown by Value for BML, Inc., Falco Biosystems Ltd., Mitsubishi Chemical Medience Corporation, Special Reference Laboratories, Inc., and Others......47
Flow Cytometry Equipment......48
Table 46: Market Shares of Leading Flow Cytometry Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Beckman Coulter, Inc. (BEC), Becton, Dickinson and Company (BDX), and Others......48
Digital Radiography......49
Table 47: Market Shares of Leading Digital Radiography (Computed Radiography (CR) Included) Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Carestream Health, Inc., General Electric (GE) Company, Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG and Others......49
Genomics......50
Table 48: Market Shares of Leading Genomics 2.0 Service Providers in the US (2015) - Percentage Breakdown by Value for Illumina, Inc., Thermo Fisher Scientific Corporation, and Others......50
Genotyping Services......51
Table 49: Market Shares of Leading Genotyping Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Affymetrix, Inc., Agilent Technologies, Illumina, Inc., and Others......51
Cancer Genetic Diagnostics......52
Table 50: Market Shares of Leading Cancer Genetic Diagnostics Reference Laboratory Services in the US (2015) - Percentage Breakdown by Value Sales for ARUP Laboratories, Clarient Diagnostic Services, Inc., Laboratory Corporation of America Holdings, Mayo Medical Laboratories, NeoGenomics, Inc., Quest Diagnostics Incorporated and AmeriPath, Inc., and Others......52
Anatomic Pathology......53
Table 51: Market Shares of Leading Anatomic Pathology Service Providers Worldwide (2015) - Percentage Breakdown by Test Volume for Hospitals, Independent Labs, Kaiser Permanente, Laboratory Corporation of America Holdings, Physician Office Labs, Quest Diagnostics Incorporated and Others......53
Table 52: Market Shares of Leading Pathology Companies in Australia (2014) - Percentage Breakdown by Value Sales for Healthscope Corporate Pathology, Primary Health Care Limited, Sonic Healthcare Limited and Others......54
Table 53: NeoGenomics, Inc.’s Revenue by Source in the US (2014) - Percentage Market Share Breakdown by Value for Clinical Trials, Oncologists & Clinicians and Pathologists and Hospital Pathology Groups......55
Table 54: NeoGenomics, Inc.’s Revenue by Category in the US (2014) - Percentage Market Share Breakdown by Value for Hematological Malignancies and Solid Tumors......56
Table 55: NeoGenomics, Inc.’s Revenue by Payer in the US (2014) - Percentage Market Share Breakdown by Value for Commercial Insurance, Hospitals/ Reference Labs, Medicare and Other Government and Patients/Others......57